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ABSTRACT
Objective To examine patterns of mortality among
climbers on Mount Everest over an 86 year period.
Design Descriptive study.
Setting Climbing expeditions to Mount Everest, 1921-
2006.
Participants 14138 mountaineers; 8030 climbers and
6108 sherpas.
Main outcome measure Circumstances of deaths.
Results The mortality rate among mountaineers above
base camp was 1.3%. Deaths could be classified as
involving trauma (objective hazards or falls, n=113), as
non-traumatic (high altitude illness, hypothermia, or
sudden death, n=52), or as a disappearance (body never
found, n=27). During the spring climbing seasons from
1982 to 2006, 82.3% of deaths of climbers occurred
during an attempt at reaching the summit. The death rate
during all descents via standard routes was higher for
climbers than for sherpas (2.7% (43/1585) v 0.4%
(5/1231), P<0.001; all mountaineers 1.9%). Of 94
mountaineers who died after climbing above 8000 m,
53 (56%)died duringdescent from the summit, 16 (17%)
after turning back, 9 (10%) during the ascent, 4 (5%)
before leaving the final camp, and for 12 (13%) the stage
ofthesummitbidwasunknown.Themediantimetoreach
the summit via standard routes was earlier for survivors
than for non-survivors (0900-0959 v 1300-1359,
P<0.001). Profound fatigue (n=34), cognitive changes
(n=21),andataxia(n=12)werethecommonestsymptoms
reported in non-survivors, whereas respiratory distress
(n=5),headache(n=0),andnauseaorvomiting(n=3)were
rarely described.
Conclusions Debilitating symptoms consistent with high
altitude cerebral oedema commonly present during
descent from the summit of Mount Everest. Profound
fatigue and late times in reaching the summit are early
features associated with subsequent death.
INTRODUCTION
At 8850 m above sea level, the summit of Mount
Everest is the highest point on earth. Since the 1920s,
thousands of mountaineers have tried to scale Everest,
and many have died during the attempt. Despite this,
Everest and other major peaks in the Himalayan
mountainrangecontinuetoattractincreasingnumbers
of climbers, with a significant associated mortality
duringexpeditions.
1-6Weexaminedthecircumstances
of deaths on Mount Everest to establish patterns of
mortality among mountaineers on a large Himalayan
peak.
METHODS
We carried out a retrospective study of all deaths
during climbing expeditions on Everest during
1921-2006. The population studied included all
members(listedonexpeditionpermits)andemployees
of these expeditions. We identified deaths through
publishedaccountsofexpeditionsandbysearchingthe
Himalayan Database, a computerised registry of
climbing expeditions to registered peaks in the
Nepalese Himalayas.
4 We located accounts of deaths
from these sources, by searching the internet or by
direct contact with mountaineers. We classified the
source of the reports as direct contact (interview or
correspondence with the authors), miscellaneous, or
based on accounts in journals, books, the Himalayan
Database,andtheinternet.Weclassifiedthereportsby
authorship: eyewitness, expedition members or
employees who were not eyewitnesses, or secondary
(authors not part of the expedition).
For statistical purposes we counted repeat visits and
successes on reaching the summit as independent
events.Wedefinedthealtitudeofdeathasthatatwhich
a fatality occurred or was estimated to have occurred,
from where a fall occurred, or from where a non-
survivor was initially evacuated. A fatal incident was
defined as an event involving one or more people on
the same expedition, or climbing together, during a
single trip between camps. In incidents where moun-
taineers died at different altitudes, we estimated the
altitude of the incident. Base camp was defined as the
final encampment on any route before technical
(roped) climbing began.
Four doctors who were experienced in managing
high altitude illness independently examined the
accounts of deaths. Three of these reviewers had
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BMJ | ONLINE FIRST | bmj.com page 1 of 6reached the summit of Everest themselves; one had
turned back at 8300 m. Two had climbed from Tibet,
andtheothertwohadclimbedfromNepal.Wepooled
the analyses.Disagreements onclassification of deaths
were resolved by consensus. Deaths involving trauma
were classified by the type of trauma. We categorised
high altitude cerebral or pulmonary oedema as high
altitudeillness,usingaccepteddiagnosticcriteria
7orby
virtue of a reliable report. We also classified deaths as
highaltitudeillnessifaspecificdiagnosisofcerebralor
pulmonary oedema could not be established, symp-
tomsof acute mountainsicknesswere present,
8and no
other primary cause of the symptoms was evident.
Death due to exposure was classified as hypothermia.
Sudden death was defined as abrupt death without
previous progressive symptoms. We listed death as
unclassified when a single primary cause could not be
established.Deathswereclassifiedasdisappearancesif
the death or the immediate cause of death was not
witnessed and the body was not found.
We examined the accounts of deaths in mountai-
neerswhoreached8000mtodeterminethestageofthe
climb, the climbing speed of the mountaineer com-
pared with team mates, and the mention of visual
disturbancesand diagnosticsymptomsofhighaltitude
illness.
8FromtheHimalayanDatabaseweobtainedthe
times mountaineers reached the summit.
4
Statistical analysis
We usedthe Fleiss’ kappamethodto analysethe inter-
rater agreement for classification of death.
9 For
univariable analyses of binary and categorical out-
comes we used a χ
2 test or Fisher’s exact test. We used
the two sided t tests or a Wilcoxon rank sum test to
comparecontinuousoutcomes,includingsummittime
and the number of deaths due to objective hazards per
incident, whenever appropriate. We used SAS soft-
ware version 9 as the main tool for statistical analysis.
Weather analysis
To assess the role of adverse weather in fatal incidents,
we examined the accounts of deaths during May from
1975to2006,asthisperiodincludedmostdeaths.Each
reviewer independently scored the probability that
adverseweathercontributedtoafataloutcomeasvery
probable (score 1), probable (2), possible (3), or
unlikely or unknown (4). By adding these weather
scores together, we identified days when deterioration
inweatherprobablydid(score≤8)ordidnot(>8)playa
partindeathsabove7000m.Wealsoidentifieddayson
the summit without deaths from the Himalayan
Database.
4 The representative meteorological condi-
tions of days with these three outcomes were then
computed using a compositing technique for the
barometric pressure at 9000 m above sea level, based
on fields from the reanalysis project of the National
Center for Environmental Prediction,
10 a dataset that
includes all available meteorological observations and
that is applicable to analysis of weather conditions on
Everest.
11-13
RESULTS
Table 1 outlines the characteristics of the study
population. Overall, 341 accounts were analysed,
including 136 notes from the Himalayan Database,
106journalreports,31books,32directaccountsby22
climbers, 14 web based accounts, and 7 miscellaneous
sources. In total, 154 fatal incidents resulting in 212
deaths were identified. Of these deaths, 72 were
reported by at least an eyewitness author, 55 by at
leastanexpeditionmemberauthor,andtheremaining
85 were solely by secondary authorship. Survivors
witnessed 127 deaths or the immediate circumstances
of death (objective hazard, sudden death, in extremis,
immediate evidence of a fall), 58 immediate circum-
stanceshadnotbeenwitnessedbutthebodywasfound,
and 27 people had disappeared without their final
moments being reported.
For the classification of all 212 deaths, there was
unanimous independent agreement for 165 (78%) of
the classifications. The Fleiss κ value for inter-rater
agreementwas0.63,P<0.001(substantialagreement).
9
Of deaths classified at all altitudes, fatal cerebral
oedema occurred at a higher altitude than fatal
pulmonary oedema (7 v 5; 8276 (SD 791) m v 6229
(SD 104) m, P=0.001). Table 2 provides the classifica-
tion of deaths above base camp; see www.himalayan
database.com for further data.
4
Above base camp, 103 incidents involving climbers
occurred at a higher mean altitude than 44 involving
sherpas(7854(SD918)mv6927(SD116)m,P<0.001).
Thirtysevenincidentsinvolvedobjectivehazards,with
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Fig 1 | Deaths on standard north and south routes of Everest during spring climbing season
(April-June) 1982-2006. Deaths during descent are above route profile and deaths before
summiting or during bids for summit with unknown outcome are below. One sherpa died below
Yak camp during evacuation. Right axis shows estimated barometric pressure during May,
14 and
percentage of oxygen at sea level (760 mm Hg) that exerts equivalent partial pressure to
atmospheric oxygen at relevant altitude. Left axis shows estimated ambient air temperature
during May.
1516 Scale on x axis is expanded by factor of two for route above 8000 m. *Two sided
Fisher’s exact test
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0.54, P=0.02). The mean altitude of events involving
objective hazards was 6381 (SD 661) m.
The death rate during all descents from the summit
viathestandardrouteswashigherforclimbersthanfor
sherpas (2.7% (43/1585) v 0.4% (5/1231), P<0.001; all
mountaineers 1.9%). Figure 1 presents the mortality
anddistributionofdeathsonthestandardroutesduring
the spring climbing seasons of 1982 to 2006. Of 77
deaths, 55 occurred during bids for the summit (51
climbers,foursherpas,71%)and22duringpreparation
of the route (11 climbers, 11 sherpas, 29%). Six
incidents involving objective hazards resulted in eight
deathsonthestandardsouthroute;nodeathsoccurred
on the north route in this category.
Table 3presentsdataonthemountaineerswhodied
afterreaching8000m.Fiftythree(56%)diedduringthe
descent,16(17%)afterturningbackbelowthesummit,
and nine (10%) during the ascent. The stage of the
summit bid was unknown for 12 mountaineers (13%),
and four (5%) died before leaving the final camp. Of a
subset of 23 mountaineers who climbed without
supplemental oxygen, 11 (48%) died during the
descent,4(17%)afterturningback,and4(17%)during
the ascent, and in 4 (17%) the stage was unknown.
Median time to reach the summit via standard routes
was earlier for survivors than for non-survivors (0900-
0959 (interquartile range 0800-0859 to 1100-1159) v
1300-1359(1100-1159to1600-1659),P<0.001).Thirty
seven mountaineers died or were in extremis in the
presence of witnesses, 34 fell behind team members
before becoming debilitated or dying, the circum-
stances of 11 were unknown as they died with all team
members and therefore without report, 11 climbed
alone, and one could not be classified as the account
was insufficient.
Of these 94 mountaineers who died, 33 had
symptoms attributable to high altitude illness and six
had symptoms of either high altitude illness or
hypothermia, or both. The symptoms and numbers
of mountaineers, respectively, were profound fatigue
or exhaustion (n=34), confusion or coma (21), ataxia
(12), respiratory disturbances (5), nausea or vomiting
(3), and headache (0). Of 32 falls, 12 were not closely
witnessed, eight involved climbers described as con-
fused or exhausted, seven occurred in treacherous
conditions,andinfivecasestheaccountswereunclear.
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Fig 2 | Composite of barometric pressure (millibars),
expressed as anomaly to long term mean pressure, at 9000 m
above sea level over Asia during May 1975-2006. Shaded
regions are those where barometric variations differ from
mean pressure (P<0.05), which is complied from a resampling
technique with 1000 randomised samples at the same
location. (a) Large region of higher than mean pressure
(P<0.05) near Everest coincides with 141 days on which
mountaineers reached the summit. (b) On days with weather
related deaths above 7000m (score ≤8), Everest is in regionof
lower than mean barometric pressure (P<0.05). (c) No
statistically significant pressure anomaly present on those
days when non-weather related deaths occurred above
7000 m (score >8). For days when mountaineers reached the
summit, average pressure anomaly in vicinity of Everest varied
from -3 mb to 5 mb, whereas for days in which a weather
related death occurred, average pressure anomaly varied from
−6 mb to 2 mb. For days in which a non-weather related death
occurred, average pressure anomaly varied from −4m bt o
5m b
Table 1 |Population characteristics of mountaineers on Everest, 1921-2006. Values are
numbers (percentages) unless stated otherwise
Variables Climbers (n=8030) Sherpas (n=6108) Total
Male 7404 (92.2) 6106 (99.9) 13 510
Female 626 (7.8) 2 (0.1) 628
Mean (SD) age (years) (range) 36.5 (8.9) (12-74) —* —
Overall total 8030 6108 14 138
Summit ascents:
1953-81 (all) 94 (5.3) 23 (1.8) 117 (3.8)
1982-2006:
S-spring 663 (37.5) 661(51.2) 1324 (43.3)
N-spring 732 (41.4) 484 (37.5) 1216 (39.8)
Other† 279 (15.8) 122 (9.4) 401 (13.1)
Total 1768 1290 3058
S-spring=standard Nepalese route via South Col or Southeast Ridge, or minor variants, during April to June; N-
spring=standard Tibetan route via North Col or Northeast Ridge, or minor variants, during April to June.
Population includes estimates of expedition size and roles of mountaineers (climbers or sherpas) for Chinese
expeditions, 1960-79, on north side of Everest. Percentages may not add up to 100% owing to rounding.
*Data were unreliable.
†All other routes such as West Ridge or North Face approaches, or attempts on all routes during seasons other
than spring.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 6Of the 27 climbers who disappeared, 12 had evidence
of neurological dysfunction or profound fatigue, 1 had
pulmonary oedema, 9 may have fallen without
evidence of previous dysfunction, and 5 disappeared
without report of their condition. Of 11 deaths
classifiedashighaltitudeillness,6wereduetocerebral
oedema, 2 involved cerebral oedema but possible
subsequent respiratory difficulties, 1 involved both
neurological and pulmonary symptoms, and 2
involved debilitating fatigue, the subsequent course
ofwhichwasunclear.Ofthe14unclassifieddeaths,the
relative contribution of hypothermia and high altitude
illness was unclear in six climbers who collapsed or
were found comatose, the non-traumatic deaths of six
climbers found dead without adequate details were
described as unknown, and in two cases accounts
conflicted. Two climbers died suddenly (one had pre-
existing asthma, the other a brain tumour), one death
involved a myocardial infarction, and two climbers
collapsed suddenly from unknown causes. One clim-
ber had noticeable cognitive impairment and fatigue
before developing severe hypothermia in a storm. Of
seven cases of visual disturbances, four were painless,
two were painful, and one was related to a brain
tumour.
During May 1975 to 2006, deaths occurred on 31%
of days when mountaineers reached the summit
(44/141; fig 2). Deterioration in weather played a part
in 25% of deaths (14/56) on 6% of these days (8/141).
Figure 2 presents a chart of mean barometric pressure
at 9000 m for days when mountaineers reached the
summit, and for weather related deaths and non-
weather related deaths above 7000 m.
DISCUSSION
This study examined the patterns of deaths over an
86 year period on Mount Everest (1921-2006). The
mortality above base camp was 1.3% (table 2). Most
sherpas were killed in incidents on the lower slopes,
whereas most climbers died above 8000 m. Climbers
typically died during descent from the summit, often
developing cognitive impairment and ataxia, symp-
toms of high altitude cerebral oedema. Profound
fatigue, late summit times, and the tendency to fall
behind companions were common early features of
non-survivors.
Strength and limitations
Thestrengthofthisstudyliesinthemeticulousrecords
kept over four decades by Katmandu based journalist
ElizabethHawley,whoseworkisthefoundationofthe
Himalayan Database.
4 An assessment of deaths was,
however, limited by the variability of accounts and
circumstances. While there was substantial agreement
betweentheindependentreviewersonclassificationof
the deaths (Fleiss’ κ=0.63, P<0.001),
9 categorisation
was achieved using a descriptive classification system.
This approach may underestimate underlying pro-
blems,suchasneurologicaldysfunctionleadingtofalls,
disappearances, or vulnerability to hypothermia at
extreme altitude. The widespread use of supplemental
oxygen may affect physiological responses to altitude,
and a precise association between altitude and symp-
toms cannot be made. Although a retrospective study
can only show an association and not prove causality,
this simple descriptive technique nevertheless allows
for broad patterns of mortality to be detected.
Comparison with other mountains
The death rate among climbers on Denali (6194 m),
Alaska, during 1903-2006 was 0.03%,
17 whereas the
overall death rate on Mount Rainier (4392 m),
Washington, during 1987-1996 was 0.02%.
1518 The
mortality among expedition members during 1950-
2006 on Himalayan peaks such as Ama Dablam (6814
m) and Cho Oyo (8201 m) were 0.46% and 0.65%,
respectively.
6 As with Everest, these four peaks are
scaled by large numbers of relatively inexperienced
climbers using standard routes.
6-18 The death rate on
Everest is therefore greater than that of lower
mountains attempted by similar populations of clim-
bers.
Distribution of deaths
The largest class of deaths involved objective hazards
such as avalanches, icefall collapses, crevasses, and
falling rock. Sherpas were killed at a greater rate per
incident than climbers (1.18 v 0.54, P=0.02), with 70%
of deaths in sherpas classified in this category. These
Table 3 |Classification of deaths above 8000 m on Everest. Values are numbers (percentages)
Category Climbers Sherpas Total
Fall 23 (28) 9 (75) 32 (34)
Disappeared 25 (31) 2 (17) 27 (29)
High altitude illness 11 (13) 0 11 (11)
Unclassified 13 (16) 1 (8) 14 (15)
Sudden death 5 (6) 0 5 (5)
Objective hazard 3 (4) 0 3 (3)
Hypothermia 2 (2) 0 2 (2)
Total 82 (87) 12 (13) 94
Percentages may not add up to 100% owing to rounding.
Table 2 |Classification of deaths of mountaineers climbing above base camp*, 1921-2006.
Values are numbers of people killed unless stated otherwise
Classification Climbers Sherpas Total
Trauma: 54 59 113
Objective hazards 20 47 67
Falls 34 12 46
Non-trauma: 46 6 52
High altitude illness 12 5 17
Hypothermia 11 0 11
Sudden death 7 0 7
Unclassified 16 1 17
Disappeared 25 2 27
Total 125 67 192
Total death rate (%) 1.6 1.1 1.3
*Last encampment on any route before technical (roped) climbing began (base camp in Nepal, advanced base
camp in Tibet).
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climbing routes, which pass below slopes prone to
avalanches and include the Khumbu Icefall, an
unstable section of glacier. The risk of death relates to
the amount of time spent in areas where these hazards
are likely to occur. Typical expeditions on Everest
involve multiple trips to place camps on the route of a
summit bid. As sherpas are employed to transport
equipment, the higher death rate per incident among
sherpascanlargelybeexplainedbymoretimespentin
the danger zones on the lower sections of the routes.
Although Everest has been climbed by many routes
during different seasons,
5 over 83% of all ascents
occurredduringthespringalongthestandardroutesin
the last 25 years of the study period (table 1). In these
expeditions, deaths from objective hazards were rare:
six incidents on the Nepal route resulted in a total of
eightdeaths,whiletherewerenoneontheTibetroute.
By contrast, 85.4% of deaths on the north route and
43.9% of deaths on the south route occurred above
8000 m (fig 1). While a typical expedition to Everest
now lasts about 60 days, 82.3% of deaths among
climbers occurred during or after the day of a summit
attempt. For modern climbers, therefore, the most
dangerous time was that spent above 8000 m.
Deaths above 8000 m
In contrast to the deaths from objective hazards at
lower altitudes, climbers died during the descent from
the summit at a greater rate than did sherpas (2.5% v
0.2%, P<0.001). On the Tibet and Nepal routes, 3.4%
and1.7%ofclimbers,respectively,didnotreturnfrom
the summit. Gross cognitive impairment and ataxia
were common among non-survivors. These progres-
sivesymptomsanddelayedpresentationareconsistent
with high altitude cerebral oedema, a vasogenic
oedema predominantly caused by failure of vascular
endothelial fluid regulation after inadequate acclima-
tisation to hypoxia.
71920 Acute hypoxaemia during
descentdue to the exhaustionof supplemental oxygen
supplies used by most climbers is another potential
explanation for this distribution of symptoms.
21 A
similar pattern of death during descent is, however,
seen in climbers with and without supplemental
oxygenabove8000m.Arterialoxygenationdecreases
during strenuous exercise at high altitude,
2223 so
maximal hypoxaemia would occur during vigorous
exertion just below the summit. However, we
identifiedonlytwocasesofsuddendeaththatoccurred
during active ascent, both in climbers using supple-
mental oxygen. Failures of supplemental oxygen
circuits during ascent are not unusual, yet we did not
detect any deaths directly attributable to this. Among
non-survivors, neurological dysfunction and possibly
the susceptibility to acute hypoxia after exhaustion of
supplementaloxygenthereforetypicallyprogresswith
time at extreme altitude. This is characteristic of the
cerebrovascular leak and disruption of fluid homo-
eostasisofhighaltitudecerebraloedema,ratherthanof
acute hypoxaemia alone. In addition, hypoxic neuro-
logical dysfunction at extreme altitude may involve
other pathophysiological mechanisms not prominent
at lower elevations.
Respiratory distress, nausea, vomiting, and head-
ache, common indicators of altitude illness at 2500-
5000 m,
719202425 were rarely noted in non-survivors
above 8000 m. This may be because people with these
symptomsaremorelikelytosurvivebecausetheyturn
backearlier.However,anecdotalaccountsoftherapid
onsetofcerebraloedemaatveryhighaltitudeswithout
preceding headache or vomiting have been
reported.
2627 The mechanisms of the headache of
cerebraloedemaareunclearbutmayrelatetotheacute
distension of the afferent innervated blood vessels and
meninges at the base of the brain during raised
intracranial pressure.
28 An acute decrease in intra-
vascular volume is a normal physiological response to
high altitude,
29 and dehydration, due to the increased
physiologicaldemandsandthepracticalitiesofmelting
sufficient snow, is a common problem above 8000 m.
Acutedecreasesinfluidvolumesmayslowtheincrease
inintracranialpressureandrelatedheadacheafterfluid
extravasation. Ataxia and confusion may occur with a
lesser degree of oedema, due to the hypoxaemia at
extremealtitude.Wespeculatethatatextremealtitude,
headache,nausea,andvomitingareunreliableheralds
of fatal cerebral oedema, whereas debilitating ataxia
and impaired consciousness present earlier than these
symptoms. Profound fatigue, reflected in significantly
later summit times, was an early symptom of sub-
sequent non-survivors.
Atmospheric factors other than hypoxia also com-
pound physiological stress at extreme altitudes.
1516
Althoughhypothermiaandstrongwindexacerbatethe
problems of a hypoxic environment, only 5.7% of
summit days during the peak summit month of May
haddeathsassociatedwithweatherthatwasworsethan
baseline (8/141, P<0.05). Painful retinal burns due to
the intenseultravioletradiationwere identifiedonlyin
two non-survivors. Mountaineering factors such as
inexperience, inadequate teamwork, and the absence
of protective ropes on the summit routes may play
significant roles. However, similar problems might be
expected on peaks such as Rainier and Denali, where
thedeathrateisconsiderablylower.
151718Thedifficulty
of rescue at extreme altitude undoubtedly increases
mortality compared with lower altitudes, but this does
notcausetheprimaryproblemsleadingtotheneedfor
rescue. Although these factors variously contribute to
WHAT IS ALREADY KNOWN ON THIS TOPIC
ThedeathrateonMountEverest isgreaterthanthatoflower mountainsattemptedbysimilar
populations of climbers
The death rate among climbers is higher than that among sherpas
WHAT THIS STUDY ADDS
Most climbers on Mount Everest die above 8000 m, usually during descent from the summit
Cognitive impairment and ataxia, symptoms of cerebral oedema, are often present
Profound fatigue and late summit times are early features of non-survivors
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cluster of deaths at extreme altitude.
Acclimatisation to extreme altitude
Sinceneurologicalsymptomsarepresentinmanynon-
survivors, critical questions include whether adequate
acclimatisationispossibleatthisaltitudeand,ifso,how
can it best be achieved.
2130 Climbers died at over six
times the rate of sherpas during the descent from the
summit. Recent trends on the standard routes are for
climbers to spend more time at lower altitudes before
making a rapid ascent, whereas sherpas spend more
time above base camp preparing the route.
21 The
differing mortality during descent may be related to
better acclimatisation by sherpas due to prolonged
time at higher altitudes. However, selection for
employment during an expedition may involve a bias
fortheabilitytoperformataltitude.Mostsherpasareof
Sherpa extraction, an ethnic group from the Nepali
highland whose name has become synonymous with
the exceptionally hardy porters of high altitude. This
group and others born and resident at high altitudes
may have superior congenital and acquired adapta-
tions to hypoxia compared with their lowland
employers.
3132 As employees, sherpas may be less
likely to climb alone and hence are more likely to be
rescued. While one subpopulation of mountaineers
can acclimatise sufficiently to climb Everest using
supplementaloxygenwithrelativelylowmortality,the
interaction and relative importance of the differences
between populations and acclimatisation profiles
requires further study.
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